Infectious Diseases
  • Article
  • Jun 12 2020

UK researchers across many disciplines are addressing COVID-19’s medical challenges and beyond — including developing new PPE materials, designing testing and diagnostic equipment, and examining the wider societal, economic and legal implications of the pandemic.

  • Article
  • Jun 10 2020

Researchers at UK are exploring the use of an antiseptic nasal spray and gargle to prevent transmission and infection of the virus among healthcare workers and non-COVID patients.

  • Video
  • Jun 9 2020

“The virus is about 120 nanometers in size — in the world of membranes, that's large. Even more so, it's not going to come as a virus by itself, flying in the air. It's going to come in the saliva, so it's going to be a much larger particle. A large particle is just not going through (this filter).”

  • Article
  • May 13 2020

A group of UK professors and scientists efforts to identify possible direct therapeutic approaches to treat COVID-19 was published in the Perspectives section of the most recent issue of Science, a journal of the American Association for the Advancement of Science (AAAS).

  • Article
  • May 11 2020

UK researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means. The research is part of UK’s CURE Alliance team, which is uniting UK researchers across disciplines in the fight against the novel coronavirus.

  • Article
  • May 7 2020

“We are pleased to be able to offer this clinical trial to patients with COVID-19 in Kentucky. While there is no standard treatment for COVID-19, this trial gives us the ability to test multiple therapies rapidly in order to identify the most promising agents.”

  • Article
  • Apr 30 2020

According to the report, confirmed COVID-19 cases in the Commonwealth would have reached a staggering 45,000 by April 25 without any state-imposed measures. For comparison, the current total of confirmed COVID-19 cases is fewer than 4,000.

  • Article
  • Apr 28 2020

The UK CURE Alliance, in collaboration with the UK Center for Clinical and Translational Science, has issued RFAs for COVID-19 funding in three categories: health, materials and methods and social sciences. Full-time UK faculty in all title series are eligible to apply.

  • Article
  • Apr 23 2020

John Thelin is a leading authority on the history of American higher education. Today, he answers some of our questions, bringing historical knowledge to contemporary discussions around COVID-19’s impact on higher education.

  • Article
  • Apr 16 2020

In response to the COVID-19 pandemic, UK's Center for Clinical and Translational Science (CCTS) has created a new biospecimen bank to support research on the novel virus. Logistical support for the biobank is led by the UK Markey Cancer Center.